Shanghai, China

Duanyang Xie

This inventor holds 1 USPTO granted patent. Top assignee: Shanghai East Hospital. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Duanyang Xie. Retrieved from https://idiyas.com/inventor/duanyang-xie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Duanyang Xie: Innovator in Ion Channel Antagonists

Introduction

Duanyang Xie is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of ion channel antagonists and blockers. His work focuses on compounds that have potential applications in treating heart disease and other related conditions.

Latest Patents

Duanyang Xie holds a patent for "Ion channel antagonists/blockers and uses thereof." This patent provides detailed information about the compounds of formula (I) or their pharmaceutically acceptable salts, stereoisomers, solvates, or prodrugs. The patent also outlines the preparation methods and applications of these compounds. The pharmaceutical compositions described in the patent are particularly useful for the treatment of heart disease and other ion channel-related diseases.

Career Highlights

Duanyang Xie is affiliated with Shanghai East Hospital, where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding and treatment of various medical conditions.

Collaborations

Duanyang Xie collaborates with notable colleagues, including Yihan Chen and Dandan Liang. Their combined expertise enhances the research and development efforts in their field.

Conclusion

Duanyang Xie's contributions to the field of ion channel antagonists represent a significant advancement in pharmaceutical research. His innovative work continues to pave the way for new treatments for heart disease and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…